JPRN-UMIN000039234已完成未知
Study of effectiveness and safety of roxadustat for renal anemia in dialysis patients - roxadustat study
agakubo Hospital0 个研究点目标入组 8 人开始时间: 2020年2月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 8
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 100years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patient with thromboembolism within 6 months after treatment, malignant tumor during treatment, eye disease during treatment, and moderate or higher liver dysfunction.
研究者
相似试验
尚未招募
2 期
A randomized controlled trial of Roxadustat in anemia of cirrhosis of liver and it's effects on HIF-1-alpha level.Anemia in patients with Cirrhosis of liver Effects of Roxadustat in correcting anemia in cirrhosis.RoxadustatHIF-1-alphaEPO levelAnemiaCirrhosis of LiverTCTR20230619004Bangabandhu Seikh Mujib Medical University,Shahbag, Dhaka-1000,Bangladesh105
尚未招募
2 期
The effect of rosuvastatin in multiple sclerosisMultiple sclerosisIRCT20210211050323N3Hamedan University of Medical Sciences40
招募中
2 期
The effect of rosuvastatin in multiple sclerosisMultiple sclerosisIRCT20210211050323N2Hamedan University of Medical Sciences40
已完成
2 期
The effect of rosuvastatin in multiple sclerosisMultiple sclerosisIRCT20210211050323N1Hamedan University of Medical Sciences40
Unknown
4 期
Short term efficacy and safety of generic rosuvastatin (K-zuva) versus brand rosuvastatin (Crestor) for the treatment in patients with hypercholesterolemiaHypercholesterlemiaHypercholesterlemia, Low Density Lipoprotein-Cholesterol, LDL-CTCTR20221209001Health System Research Institute240